We investigated this feature in cell lines from breast, prostate, lung and pancreatic tumours by evaluating the presence of cell death markers (PARP cleavage, cleaved Caspase-3, secreted HMGB1)47 by western blot analysis (Fig. 7b and Supplementary Fig. 7c). This evidence concerns the gene CASP3 and pancreatic neoplasm.